Novel African Rhinolophus bat ACE2 sequences reveal the determinants of Afro-Eurasian sarbecovirus entry
Journal of Virology · 2026
DOI: 10.1128/jvi.00540-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Yueying Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Chiroptera, Angiotensin-Converting Enzyme 2, Peptidyl-Dipeptidase A, Virus Internalization. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, SHIONOGI Infectious Disease Research Promotion Foundation, AIST KAKUSEI project.
Abstract (Originalsprache)
Sarbecoviruses, including SARS-CoV and SARS-CoV-2, are frequently linked to Rhinolophus bats as their putative natural reservoirs. Angiotensin-converting enzyme 2 (ACE2), a host carboxypeptidase widely expressed in mammalian tissues, plays a critical role in sarbecovirus infection by serving as the cellular receptor for the viral spike (S) protein. Given the recent human outbreaks and pandemics caused by members of sarbecoviruses and the wide distribution of Rhinolophus bats, it is essential to maintain surveillance of these viruses while improving our understanding of their interactions with bat hosts, particularly the ACE2 receptor. However, while Rhinolophus bats from Asia have been relatively well studied, African Rhinolophus bats remain underrepresented and require further investigation. In this study, five Rhinolophus bat lung samples were obtained from Zambia, and ACE2 genes from these individuals were cloned and sequenced. We further evaluated the susceptibility of ACE2 variants to a panel of sarbecoviruses, revealing key residues that influence viral infectivity. ACE2 polymorphism was observed among Rhinolophus simulator individuals, revealing multiple ACE2 genotypes within the sampled population. However, R. simulator ACE2s did not permit infection by the clade 3 Afro-Eurasian sarbecoviruses tested in this study. Notably, the RhGB01 and BM48-31 viruses utilized only Rhinolophus blasii ACE2. Mutational analyses further suggested that ACE2 residues 31 and 41 play important roles in modulating spike-ACE2 interactions. This study reports four unique ACE2 sequences of R. simulator and R. blasii , and provides new insights into the molecular interactions between African Rhinolophus species ACE2s and the S protein of sarbecoviruses circulating in Africa and Europe. IMPORTANCE As putative natural reservoirs of sarbecoviruses, including SARS-CoV and SARS-CoV-2, Rhinolophus bats play a critical role in the emergence of zoonotic coronaviruses, making it essential to understand their interactions with these viruses for future pandemic preparedness. While Asian Rhinolophus bats have been relatively well studied, African species remain underrepresented, highlighting the need for further investigation. In this study, we cloned and sequenced ACE2 genes of five Rhinolophus bats collected in Zambia, Africa. We identified ACE2 polymorphism among Rhinolophus simulator individuals, although this variation was not associated with susceptibility to the clade 3 Afro-Eurasian sarbecoviruses examined. In addition, we identified key ACE2 residues that govern SARS-CoV-2 spike-ACE2 interactions and contribute to distinct infectivity patterns across species. These findings expand our understanding of the molecular determinants of sarbecovirus host range and support improved surveillance and risk assessment of emerging coronaviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
- Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
- One Health Research Center, Hokkaido University, Sapporo, Japan.
- Department of Disease Control, School of Veterinary Medicine, The University of Zambia, Lusaka, Zambia.
ORCID-Profile: Yueying Zhang, Shigeru Fujita, Ayato Takada, Kei Sato
Förderung
- Japan Agency for Medical Research and Development
- SHIONOGI Infectious Disease Research Promotion Foundation
- AIST KAKUSEI project
- The Cooperative Research Program (Joint Usage/Research Center program) of Institute for Life and Medical Sciences, Kyoto University
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Mitsubishi UFJ Financial Group, Inc. Vaccine Development Grant
Zitieren
APA
Zhang, Y., Fujita, S., Kajihara, M., Changula, K., Hang'ombe, B. M., Kawakubo, S., Lytras, S., Ito, J., Kanai, A., Suzuki, Y., Takada, A., & Sato, K. (2026). Novel African Rhinolophus bat ACE2 sequences reveal the determinants of Afro-Eurasian sarbecovirus entry. Journal of Virology. https://doi.org/10.1128/jvi.00540-26
Vancouver
Zhang Y, Fujita S, Kajihara M, Changula K, Hang'ombe BM, Kawakubo S, et al. Novel African Rhinolophus bat ACE2 sequences reveal the determinants of Afro-Eurasian sarbecovirus entry. Journal of Virology. 2026. doi:10.1128/jvi.00540-26
BibTeX
@article{Zhang2026,
author = {Zhang, Yueying and Fujita, Shigeru and Kajihara, Masahiro and Changula, Katendi and Hang'ombe, Bernard Mudenda and Kawakubo, Shusuke and Lytras, Spyros and Ito, Jumpei and Kanai, Akinori and Suzuki, Yutaka and Takada, Ayato and Sato, Kei},
title = {Novel African Rhinolophus bat ACE2 sequences reveal the determinants of Afro-Eurasian sarbecovirus entry},
journal = {Journal of Virology},
year = {2026},
doi = {10.1128/jvi.00540-26}
}
EUVIMED